Phibro Animal Health
PAHC
136 hedge funds and large institutions have $356M invested in Phibro Animal Health in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 44 increasing their positions, 55 reducing their positions, and 30 closing their positions.
1.04% less ownership
Funds ownership: 102.83% → 101.79% (-1%)
12% less funds holding
Funds holding: 154 → 136 (-18)
20% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 55
35% less capital invested
Capital invested by funds: $548M → $356M (-$192M)
57% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$4.2M |
| 2 |
Millennium Management
New York
|
+$3.85M |
| 3 |
Renaissance Technologies
New York
|
+$2.88M |
| 4 |
CSC
Cove Street Capital
El Segundo,
California
|
+$2.61M |
| 5 |
Morgan Stanley
New York
|
+$2.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CRCP
Copper Rock Capital Partners
Boston,
Massachusetts
|
-$10.1M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$4.17M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$3.36M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$2.51M |
| 5 |
Bessemer Group
Woodbridge,
New Jersey
|
-$1.81M |
PAHC Hedge Fund Activity: Q3 2020 in Review
136 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q3 2020, worth a combined $356M — down 35% from $548M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of PAHC and 13 opened new positions — a net loss of 17 holders — while 55 trimmed existing stakes and 44 added.
The largest buyer was Amundi Asset Management US, adding an estimated $4.2M. The largest seller was Copper Rock Capital Partners, exiting entirely with an estimated $10.1M sold.
- 136 institutional investors held Phibro Animal Health (PAHC) as of Q3 2020, down from 154 in Q2 2020.
- Funds reported $356M of Phibro Animal Health stock for Q3 2020, down 35% quarter-over-quarter.
- 13 funds opened new Phibro Animal Health positions in Q3 2020 and 30 closed out, a net change of -17 holders.
- The largest Phibro Animal Health buyer in Q3 2020 was Amundi Asset Management US, an estimated $4.2M added.
- The largest Phibro Animal Health seller in Q3 2020 was Copper Rock Capital Partners, an estimated $10.1M sold.
Based on aggregated 13F filings for Q3 2020.